Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: M.D. Anderson Cancer Center
Condition: Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7
NCT01585194
Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.